Is sodium chloride worth its salt?

Critical Care

Volumn 17, Issue 3, 2013, Pages

  McIntosh, Euan ^a,b   Andrews, Peter J ^c,d  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b The Army Medical Corps   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BALANCED SALT SOLUTION; ELECTROLYTE; HETASTARCH; HYPOTONIC SOLUTION; SODIUM CHLORIDE; CRYSTALLOID; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION;

BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; BRAIN PERFUSION; COLLOID; CRYSTALLOID; ELECTROLYTE BALANCE; FLUID RESUSCITATION; HUMAN; HYPERCHLOREMIA; HYPERCHLOREMIC ACIDOSIS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; METABOLIC ACIDOSIS; MORTALITY; NOTE; OSMOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BRAIN INJURIES; FEMALE; FLUID THERAPY; MALE; PROCEDURES;

BRAIN INJURIES; FEMALE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; ISOTONIC SOLUTIONS; MALE; SODIUM CHLORIDE;

EID: 84878942628     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc12732     Document Type: Note

References (9)

1. Roquilly A, Loutrel O, Cinotti R, Rosenczweig E, Flet L, Mahe PJ, Dumont R, Chupin AM, Peneaux C, Lejus C, Blanloeil Y, Volteau C, Asehnoune K. Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomized double-blind pilot study. Crit Care 2013, 17:R77. 10.1186/cc12686, 23601796.
2. Cooper DJ, Myburgh J, Heritier S, Finfer S, Bellomo R, Billot L, Murray L, Vallance The Safe-Tbi Investigators And The Australian And New Zealand Intensive Care Society Clinical Trials Group S Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality?. J Neurotrauma 2013, 30:512-518. 10.1089/neu.2012.2573, 23194432, Vallance The Safe-Tbi Investigators And The Australian And New Zealand Intensive Care Society Clinical Trials Group S.
3. Tommasino C. Fluids and the neurosurgical patient. Anesthesiology Clin North America 2002, 20:329-346.
4. , Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007, 24:S1-S106. 10.1089/neu.2006.0209, 17511535, Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons.
5. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983, 61:1444-1461. 10.1139/y83-207, 6423247.
6. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367:124-134. 10.1056/NEJMoa1204242, 22738085.
7. Estrada CA, Murugan R. Hydroxyethyl starch in severe sepsis: end of starch era?. Crit Care 2013, 17:310. 10.1186/cc12531, 23509901.
8. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP, James MF, Mythen MG, O'Malley CM, Roche AM, Rowan K. Perioperative buffered versus non-buffered fluid administration for surgery in adults. Cochrane Database Syst Rev 2012, 12:CD004089.
9. Ker K, Perel P, Blackhall K, Roberts I. How effective are some common treatments for traumatic brain injury?. BMJ 2008, 337:a865. 10.1136/bmj.a865, 18703657.